Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.4.0.3
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Consolidated Statements of Operations [Abstract]    
Sales $ 236,000
Cost of Sales 464,377
Gross loss (228,377)
Operating Expenses    
Selling, general and administrative 1,170,992 $ 1,068,247
Research and development 2,940,940 847,133
Total operating expenses 4,111,932 1,915,380
Interest expense, net 39,703 143,978
Net loss $ (4,380,012) $ (2,059,358)
Basic and diluted loss per share $ (0.23) $ (0.13)
Weighted average number of common shares outstanding 18,816,474 15,279,821